ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2683

The Discovery of Novel Splicing Variants of Neurogranin and Their Role in the Pathogenesis of Systemic Lupus Erythematosus

Xiaofang Luo1, Xuelan He1, Chaonan Wu1, Juan Ni1, Ling li Dong2 and Shouxin Li2, 1Department of Rheumatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, 2Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Calcium, polymerase chain reaction (PCR) and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis: T and B Cell Signaling and Genetic Variants

Session Type: Abstract Submissions (ACR)

Background/Purpose

Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease with a diverse array of clinical manifestations that is characterized by the production of antibodies to components of the cell nucleus. Neurogranin(Ng), a calmodulin binding protein, was thought to be a neural-specific factor involved in learning and memory, while, its ectopic expression was found in peripheral blood cells, like T lymphocytes, B lymphocytes, etc. And its role in SLE has not been reported yet. Our aim was to compare the expression and structure of Ng in peripheral blood and central nervous system (CNS), and to explore its role in SLE.

Methods

Thirty-four patients with SLE and 22 healthy controls were enrolled. Splicing variants of Ng gene in peripheral blood mononuclear cells(PBMCs) were screened with  reverse transcription polymerase chain reaction (RT-PCR) combined with T/A clone, DNA sequencing , and reconfirmed using the primer-specific PCR . Expression of Ng splicing variants mRNA was detected by qRT-PCR. All subjects gave written informed consent prior to enrollment in the study, which was approved by the ethics committee of our hospital.

Results

Three splicing variants of Ng gene were cloned from SLE PBMCs, and two of which, named as Ng-mu1 and Ng-mu2 respectively, were not been reported yet.  Compared to wild type of Ng (Ng-WT), Ng-mu1 containing of a 55 bp intron retention insertion with 256-392 base sites deleted, Ng-mu2 with second exon partially deleted and termination codon early emerged. The IQ motifs of Ng-mu1 which is the binding site of calmodulin were impaired (Fig1). The ratio of Ng-WT to Ng-mu1 in healthy control PBMCs was lower than human brain total RNA. Further analysis showed the up-regulation of Ng-WT mRNA and the elevated ratio of Ng-WT to Ng-mu1 in SLE PBMCs, and the expression of Ng-WT was positively correlated with SLE disease activity index (SLEDAI) (Fig2).

Conclusion

The novel splicing variants of Ng and their ectopic expression in PBMCs may contribute to the pathogenesis of SLE through mediating Ca2+ signal transduction.

˵Ã÷: C:UsersmiaoDesktopNGACRfigure1.jpg

Fig1. Three splicing variants of Ng gene. A: Comparison of IQ motif of Ng-WT, Ng-mu1 and Ng-mu2. B: Schematic diagram of forming of Ng-WT, Ng-mu1 and Ng-mu2. C: Agarose gels with the analysis of the cDNA of Ng gene fragment with primers F2 and R2 as in fig1B. D: Agarose gels with the analysis of the cDNA of Ng with specific primers F2 and R2′ as in fig1B.

˵Ã÷: C:UsersmiaoDesktopNGACRfigure2.jpg

Fig2. Relative expression of Ng-WT mRNA and Ng-mu1 mRNA in SLE PBMCs. A: Expression of Ng-WT mRNA. B: Expression of Ng-mu1 mRNA. C: The ratio of Ng-WT to Ng-mu1. D: Expression of Ng-WT was positively correlated with SLEDAI.

 


Disclosure:

X. Luo,
None;

X. He,
None;

C. Wu,
None;

J. Ni,
None;

L. L. Dong,
None;

S. Li,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-discovery-of-novel-splicing-variants-of-neurogranin-and-their-role-in-the-pathogenesis-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology